Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study.

Cite this paper

@article{Demiray2006ResponseTN, title={Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study.}, author={M Demiray and Engin Engin Ulukaya and Murat Arslan and Sehsuvar Gokgoz and Ozlem Saraydaroğlu and Ilker Ercan and Turkkan Evrensel and Osman Manavoğlu}, journal={Cancer investigation}, year={2006}, volume={24 7}, pages={669-76} }